A review of glucagon‐like peptide‐1 receptor agonists and their effects on lowering postprandial plasma glucose and cardiovascular outcomes in the treatment of type 2 diabetes mellitus-Reference-Cited by-同舟云学术

A review of glucagon‐like peptide‐1 receptor agonists and their effects on lowering postprandial plasma glucose and cardiovascular outcomes in the treatment of type 2 diabetes mellitus

Published:2017-07-11 Issue:12 Volume:19 Page:1645-1654
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Owens David R.¹^ORCID,Monnier Louis²,Hanefeld Markolf³^ORCID

Affiliation:

1. Diabetes Research Group, Institute of Life Sciences College of MedicineSwansea University Swansea UK

2. Laboratory of Human Nutrition and Atherosclerosis, Institute of Clinical ResearchUniversity of Montpellier Montpellier France

3. Study Centre “Professor Hanefeld”GWT‐Technical University Dresden Dresden Germany

Funder

Sanofi

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.12998

Reference97 articles.

1. Self‐reported heart disease and stroke among adults with and without diabetes ‐ United States, 1999 to 2001: a report of the Center for Disease Control and Prevention;Benjamin SM;MMWR Morb Mortal Wkly Rep,2003

2. Diabetes and Cardiovascular Disease

3. 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes

4. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

5. Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comprehensive Review of the Effects of Glycemic Carbohydrates on the Neurocognitive Functions Based on Gut Microenvironment Regulation and Glycemic Fluctuation Control;Nutrients;2023-12-12

2. Beyond the Cardiovascular Effects of Glucagon-like Peptide-1 Receptor Agonists: Body Slimming and Plaque Stabilization. Are New Statins Born?;Biomolecules;2023-11-23

3. Glycaemic variabilities: Key questions in pursuit of clarity;Diabetes & Metabolism;2021-11

4. miR‐381‐3p inhibits high glucose‐induced vascular smooth muscle cell proliferation and migration by targeting HMGB1;The Journal of Gene Medicine;2020-09-28

5. Glycaemic and non‐glycaemic efficacy of once‐weekly GLP‐1 receptor agonists in people with type 2 diabetes;Journal of Clinical Pharmacy and Therapeutics;2020-09